posts category

Press Room

–  License and Supply Agreement with Thermo Fisher Scientific signed at Macrogen headquarters – Further development of the global CES market expected by expanding Macrogen’s “Genome Supermarket” strategy SEOUL, South Korea–Kap-Seok Yang, CEO of Macrogen (KOSDAQ: 038290), announced on January 13 that the company …

Continue reading

ROCKVILLE, MD–On January 2nd, the Psomagen–Macrogen Consortium announced the acquisition of all key assets of US company uBiome. Through the move, Psomagen has become a key player in the microbiome sector, a promising next-generation bio healthcare industry, with a competitive advantage in the US and …

Continue reading

– The largest number of regions and races included in any Asian reference panel – Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo) (KOSDAQ: 038290) announced on Dec 4 that …

Continue reading

– Reference panel expected to contribute to discover the Northeast Asian specific illness-related genes, and to develop tailored diagnosis method – A second reference panel from 10,000 individuals will release early next year SEOUL, South Korea–The joint research team from Seoul National University Bundang Hospital and …

Continue reading

– Patent granted for blockchain technology for data transaction brokerage and sharing between data providers and users – Allows individuals to have control over their healthcare data – Technology to be used by Psomagen to build healthcare big data for the U.S. DTC market SEOUL, South Korea— The precision …

Continue reading